Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Portage Biotech Inc. (PRTG)

Compare
8.26
-0.99
(-10.70%)
At close: April 1 at 4:00:00 PM EDT
8.35
+0.09
+(1.09%)
After hours: April 1 at 6:30:41 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Expense
11,758
18,253
16,576
15,588
12,440
Operating Income
-11,758
-18,253
-16,576
-15,588
-12,440
Net Non Operating Interest Income Expense
188
242
208
-43
-177
Other Income Expense
-65,241
-67,919
-106,154
814
-2,275
Pretax Income
-76,811
-85,930
-122,522
-14,817
-14,892
Tax Provision
-9,494
-10,548
-17,856
4,352
2,297
Net Income Common Stockholders
-67,278
-75,339
-104,611
-16,870
-15,833
Diluted NI Available to Com Stockholders
-67,278
-75,339
-104,611
-16,870
-15,833
Basic EPS
-68.17
-77.80
-129.80
-25.80
-27.00
Diluted EPS
-68.17
-77.80
-129.80
-25.80
-27.00
Basic Average Shares
1,054.65
967.15
805.95
653
586.65
Diluted Average Shares
1,054.65
967.15
805.95
653
586.65
Total Operating Income as Reported
-11,715
-18,199
-16,575
-15,588
-12,440
Total Expenses
11,758
18,253
16,576
15,588
12,440
Interest Income
220
274
217
--
--
Interest Expense
--
32
9
43
177
Net Interest Income
188
242
208
-43
-177
Net Income from Continuing & Discontinued Operation
-67,278
-75,339
-104,611
-16,870
-15,833
Normalized Income
-10,961.55
-16,697.54
-14,149.68
-17,562.04
-15,446.83
EBIT
-79,403
-85,898
-122,513
-14,774
-14,715
EBITDA
-79,360
-85,844
-122,512
-14,774
-14,715
Reconciled Depreciation
43
54
1
--
--
Net Income from Continuing Operation Net Minority Interest
-67,278
-75,339
-104,611
-16,870
-15,833
Total Unusual Items Excluding Goodwill
-64,259
-66,847
-105,894
876
-529
Total Unusual Items
-64,259
-66,847
-105,894
876
-529
Normalized EBITDA
-15,101
-18,997
-16,618
-15,650
-14,186
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-7,942.55
-8,205.54
-15,432.68
183.96
-142.83
3/31/2021 - 1/2/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OSRH OSR Holdings, Inc.
1.7200
-8.51%
 
DBVT DBV Technologies S.A.
6.46
-5.28%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.4641
+0.72%
 
DRMA Dermata Therapeutics, Inc.
0.9997
-7.44%
 
OCEA Ocean Biomedical, Inc.
0.0549
+1.67%
 
THTX Theratechnologies Inc.
1.4000
0.00%
 
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
 
SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
 
PSTV Plus Therapeutics, Inc.
1.0200
+7.36%
 
SLNO Soleno Therapeutics, Inc.
68.26
-4.46%